Hydrogen Improves Glycemic Control in Type1 Diabetic Animal Model by Promoting Glucose Uptake into Skeletal Muscle

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Amitani, Haruka ^a   Asakawa, Akihiro ^a   Cheng, Kaichun ^a   Amitani, Marie ^a   Kaimoto, Kaori ^a   Nakano, Masako ^a   Ushikai, Miharu ^a   Li, Yingxiao ^a   Tsai, Minglun ^a   Li, Jiang Bo ^a   Terashi, Mutsumi ^a   Chaolu, Huhe ^a   Kamimura, Ryozo ^a   Inui, Akio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETYLCYSTEINE; ASCORBIC ACID; CARBON 14; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; HYDROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; SODIUM CHLORIDE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DISEASE MODEL; FLUID INTAKE; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID DIET; MALE; MOUSE; MUSCLE FIBER MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEP G2 CELLS; HUMANS; HYDROGEN; MICE; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; PROTEIN KINASES;

ANIMALIA; MUS;

EID: 84872257429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053913     Document Type: Article

References (72)

1. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
2. Rinderknecht E, Humbel RE, (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253: 2769-2776.
3. Guler HP, Zapf J, Froesch ER, (1987) Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317: 137-140.
4. Frystyk J, (2005) The growth hormone hypothesis- 2005 revision. Horm Metab Res 37Suppl 1: 44-48.
5. Gammeltoft S, Van Obberghen E, (1986) Protein kinase activity of the insulin receptor. Biochem J 235: 1-11.
6. Taniguchi CM, Emanuelli B, Kahn CR, (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7: 85-96.
7. Levitt MD, (1969) Production and excretion of hydrogen gas in man. N Engl J Med 281: 122-127.
8. Ghoshal UC, (2011) How to interpret hydrogen breath tests. J Neurogastroenterol Motil 17: 312-317.
9. Gharib B, Hanna S, Abdallahi OM, Lepidi H, Gardette B, et al. (2001) Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation. C R Acad Sci III 324: 719-724.
10. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, et al. (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13: 688-694.
11. Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, et al. (2009) Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett 453: 81-85.
12. Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S, (2008) Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem Biophys Res Commun 377: 1195-1198.
13. Fujita K, Seike T, Yutsudo N, Ohno M, Yamada H, et al. (2009) Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. PLoS One 4: e7247.
14. Chen H, Sun YP, Li Y, Liu WW, Xiang HG, et al. (2010) Hydrogen-rich saline ameliorates the severity of l-arginine-induced acute pancreatitis in rats. Biochem Biophys Res Commun 393: 308-313.
15. Itoh T, Fujita Y, Ito M, Masuda A, Ohno K, et al. (2009) Molecular hydrogen suppresses FcepsilonRI-mediated signal transduction and prevents degranulation of mast cells. Biochem Biophys Res Commun 389: 651-656.
16. Kamimura N, Nishimaki K, Ohsawa I, Ohta S, (2011) Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity (Silver Spring) 19: 1396-1403.
17. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, et al. (2008) Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res 28: 137-143.
18. Chang CJ, Kao JT, Lee TL, Lai CW, Cheng JT, (1996) Comparison of isoproterenol with BRL37344 in activation of beta 3-adrenoceptors to inhibit the uptake of [14C]deoxy-D-glucose and translocation of glucose transporter (GLUT4) to membrane fraction in rat adipocytes. J Auton Nerv Syst 61: 191-194.
19. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN, (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37: 1163-1167.
20. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
21. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
22. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, et al. (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495.
23. van Belle TL, Coppieters KT, von Herrath MG, (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91: 79-118.
24. Garg V, (2011) Noninsulin pharmacological management of type 1 diabetes mellitus. Indian J Endocrinol Metab 15: S5-S11.
25. Balaban RS, Nemoto S, Finkel T, (2005) Mitochondria, oxidants, and aging. Cell 120: 483-495.
26. Giordano FJ, (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115: 500-508.
27. Droge W, (2002) Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
28. Chance B, Sies H, Boveris A, (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605.
29. Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N, (2010) Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr 46: 140-149.
30. Xie K, Yu Y, Pei Y, Hou L, Chen S, et al. (2010) Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock 34: 90-97.
31. Aruoma OI, Halliwell B, Hoey BM, Butler J, (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6: 593-597.
32. Neuschwander-Tetri BA, Bellezzo JM, Britton RS, Bacon BR, Fox ES, (1996) Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer cells. Biochem J 320 (Pt 3): 1005-1010.
33. Song M, Kellum JA, Kaldas H, Fink MP, (2004) Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J Pharmacol Exp Ther 308: 307-316.
34. Kelly GS, (1998) Clinical applications of N-acetylcysteine. Altern Med Rev 3: 114-127.
35. Oikawa S, Yamada K, Yamashita N, Tada-Oikawa S, Kawanishi S, (1999) N-acetylcysteine, a cancer chemopreventive agent, causes oxidative damage to cellular and isolated DNA. Carcinogenesis 20: 1485-1490.
36. Sagrista ML, Garcia AE, Africa De Madariaga M, Mora M, (2002) Antioxidant and pro-oxidant effect of the thiolic compounds N-acetyl-L-cysteine and glutathione against free radical-induced lipid peroxidation. Free Radic Res 36: 329-340.
37. Su M, Yang Y, Yang G, (2006) Quantitative measurement of hydroxyl radical induced DNA double-strand breaks and the effect of N-acetyl-L-cysteine. FEBS Lett 580: 4136-4142.
38. Wang AL, Wang JP, Wang H, Chen YH, Zhao L, et al. (2006) A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice. Hepatol Res 34: 199-206.
39. Childs A, Jacobs C, Kaminski T, Halliwell B, Leeuwenburgh C, (2001) Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic Biol Med 31: 745-753.
40. Ames BN, (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221: 1256-1264.
41. Frei B, Stocker R, Ames BN, (1988) Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 85: 9748-9752.
42. Herbert V, Shaw S, Jayatilleke E, (1996) Vitamin C-driven free radical generation from iron. J Nutr 126: 1213S-1220S.
43. Galley HF, Davies MJ, Webster NR, (1996) Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 20: 139-143.
44. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, et al. (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285: 8375-8382.
45. Siu PM, Wang Y, Alway SE, (2009) Apoptotic signaling induced by H2O2-mediated oxidative stress in differentiated C2C12 myotubes. Life Sci 84: 468-481.
46. Bak MJ, Jun M, Jeong WS, (2012) Antioxidant and Hepatoprotective Effects of the Red Ginseng Essential Oil in H(2)O(2)-Treated HepG2 Cells and CCl(4)-Treated Mice. Int J Mol Sci 13: 2314-2330.
47. Klip A, Paquet MR, (1990) Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13: 228-243.
48. Yaffe D, Saxel O, (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
49. Farese RV, (2002) Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol Endocrinol Metab 283: E1-11.
50. Mihaylova MM, Shaw RJ, (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13: 1016-1023.
51. Huang S, Czech MP, (2007) The GLUT4 glucose transporter. Cell Metab 5: 237-252.
52. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert M, et al. (2002) Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport. J Biol Chem 277: 23554-23562.
53. Morgan NG, Cable HC, Newcombe NR, Williams GT, (1994) Treatment of cultured pancreatic B-cells with streptozotocin induces cell death by apoptosis. Biosci Rep 14: 243-250.
54. Kroncke KD, Fehsel K, Sommer A, Rodriguez ML, Kolb-Bachofen V, (1995) Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage. Biol Chem Hoppe Seyler 376: 179-185.
55. Delaney CA, Dunger A, Di Matteo M, Cunningham JM, Green MH, et al. (1995) Comparison of inhibition of glucose-stimulated insulin secretion in rat islets of Langerhans by streptozotocin and methyl and ethyl nitrosoureas and methanesulphonates. Lack of correlation with nitric oxide-releasing or O6-alkylating ability. Biochem Pharmacol 50: 2015-2020.
56. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S, (2000) Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43: 1528-1533.
57. Havrankova J, Roth J, Brownstein M, (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272: 827-829.
58. Marks JL, Porte D Jr, Stahl WL, Baskin DG, (1990) Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 127: 3234-3236.
59. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, et al. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289: 2122-2125.
60. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, et al. (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68-100.
61. Inui A, (2001) Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2: 551-560.
62. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG, (2000) Central nervous system control of food intake. Nature 404: 661-671.
63. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660.
64. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. (2001) A role for ghrelin in the central regulation of feeding. Nature 409: 194-198.
65. Ishii S, Kamegai J, Tamura H, Shimizu T, Sugihara H, et al. (2002) Role of ghrelin in streptozotocin-induced diabetic hyperphagia. Endocrinology 143: 4934-4937.
66. Dong J, Peeters TL, De Smet B, Moechars D, Delporte C, et al. (2006) Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes. Endocrinology 147: 2634-2642.
67. Murdolo G, Lucidi P, Di Loreto C, Parlanti N, De Cicco A, et al. (2003) Insulin is required for prandial ghrelin suppression in humans. Diabetes 52: 2923-2927.
68. Xu Y, Elmquist JK, Fukuda M, (2011) Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann N Y Acad Sci 1243: 1-14.
69. RA D, (1997) Pathogenesis of type 2 diabetes mellitus: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5: 177-269.
70. American Diabetes A, (2010) Standards of medical care in diabetes-2010. Diabetes Care 33Suppl 1: S11-61.
71. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S, (2009) Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Neuropsychopharmacology 34: 501-508.
72. Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S, (2009) Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol 64: 753-761.